Trial intelligence / Profile preview

Methylprednisolone vs Dexamethasone in COVID-19 Pneumonia

NCT04636671Phase 3Completed

Sponsor
University of Trieste
Start
Apr 2021
Primary completion
May 2022
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of methylprednisolone in COVID-19 pneumonia, sponsored by University of Trieste. Started Apr 2021; status: completed.

02

Drugs

methylprednisolone
03

Conditions

COVID-19 pneumonia

Beyond the preview

Go deeper on NCT04636671.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04636671.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call